[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both ...

The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses compared to teriflunomideIn a pivotal PPMS study ...

Buy Aurobindo Pharma; target of Rs 1350: ICICI Securities

ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1350 in its ...

US$7.50: That's What Analysts Think Sensus Healthcare, Inc. (NASDAQ:SRTS) Is Worth After Its Latest Results

Sensus Healthcare, Inc. (NASDAQ:SRTS) just released its quarterly report and things are looking bullish. Results overall were solid, with revenues arriving 9.0% better than analyst forecasts at ...
Opinion

When the soundtrack of your youth becomes a TV commercial

The first time I heard “ Situation ” by Yaz, a British synth-pop duo, I was in a lesbian club filled with mostly closeted college women in Syracuse, N.Y. With Alison Moyet’s soulful, sexy vocals ...